MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway
Crossref DOI link: https://doi.org/10.1007/s10616-017-0134-z
Published Online: 2017-09-08
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Amini-Farsani, Zeinab
Sangtarash, Mohammad Hossein
Shamsara, Mehdi
Teimori, Hossein
Funding for this research was provided by:
This work was supported by Shahrekord University of Medical Sciences, Shahrekord, Iran (1837)
License valid from 2017-09-08